We are updating the design of this site. Learn more.
Show more
ClinicalTrials.gov
ClinicalTrials.gov Menu
Trial record 1 of 1 for:    EC-FV-06
Previous Study | Return to List | Next Study

Study for Women With Platinum Resistant Ovarian Cancer Evaluating EC145 in Combination With Doxil® (PROCEED) (PROCEED)

This study has suspended participant recruitment.
(DSMB decision)
Sponsor:
ClinicalTrials.gov Identifier:
NCT01170650
First Posted: July 27, 2010
Last Update Posted: August 4, 2015
The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
Information provided by (Responsible Party):
Endocyte
No Study Results Posted on ClinicalTrials.gov for this Study
  Study Status: This study has suspended participant recruitment.
  Estimated Study Completion Date: October 2016
  Primary Completion Date: May 2015 (Final data collection date for primary outcome measure)